Genetic mutation testing for melanoma

The Know Now Testing Program, a Novartis initiative in collaboration with Quest Diagnostics, offers genetic mutation testing at no cost for all patients with stage III or stage IV melanoma. Melanoma is an aggressive and often deadly form of skin cancer. Nearly 100,000 adults in the United States will be diagnosed with melanoma this year and approximately seven percent will die from melanoma.

Nearly half of all advanced melanoma patients carry a specific mutation, called BRAF. It's important for patients to get tested and know their BRAF status as it is a key piece of information when evaluating treatment options.

Results from tests completed under the Know Now Testing Program are available approximately 48 hours after a Quest Diagnostics laboratory receives a sample, which could lead to timely and optimal treatment decisions. To access the Know Now program and its no-cost testing, healthcare professionals should visit www.knownowbraf.com and download the BRAF Test Request Form.

 

Other news

Upcoming Events

IBMS Biomedical Science Congress

ICC, Birmingham
22-25 September 2019

Lab Innovations

NEC, Birmingham (Hall 12)
30 & 31 October 2019

The genomic and molecular revolution in microbiology: in technology we trust (or do we?).

RAF Museum, Hendon, London
14 May 2020

Clinical and Laboratory Haemostasis 2020

STEM/Atrium Conference Centre, Sheffield Hallam University
3-4 June 2020

Latest Issue

Pathology In Practice

Pathology In Practice

Aug 2019

Meet Epredia: introducing a team you already know

Register now to apply for regular copies of Pathology In Practice and free access to premium content, as well as our regular newsletters.